Download - Basal Cell Epithelioma2
-
8/4/2019 Basal Cell Epithelioma2
1/16
A slow- growing, destructive skin tumor,basal cell epithelioma or carcinoma usuallyoccurs in persons older than age-40; itsmore prevalent in blond, fair skinned menand is most common malignant tumor
affecting white.
-
8/4/2019 Basal Cell Epithelioma2
2/16
Changes in Epidermal basal cells candiminish maturation andkeratinization.Continuing division of basalcells leads to mass formation. The threetypes are nodular ulcerative lesion,superficial basal cell epithelioma and
sclerosing basal cell epithelioma.
-
8/4/2019 Basal Cell Epithelioma2
3/16
Arsenic ingestionBurnsImmunosuppressionProlonged sun exposure ( most common)Radiation exposureVaccination (rare)
-
8/4/2019 Basal Cell Epithelioma2
4/16
Occur most commonly on the face,particularly the forehead, eyelid marginsand nasolabial folds.early lesions: small, smooth, pinkish, andtranslucent papules; telangiectatic vesselcrossing the surface; occasionally
pigmented.later lesions: center depressed; bordersfirm and elevated.
-
8/4/2019 Basal Cell Epithelioma2
5/16
Results in ulceration and local invasion (known as rodent ulcers; rarely metastasizebut if untreated , can spread to vital areasand become infected; can cause massivehemorrhage if they invade large bloodvessels).
-
8/4/2019 Basal Cell Epithelioma2
6/16
Numerous; commonly on chest and back.Oval or irregularly shaped, lightly pigmented
plaques, with sharply defined, sligthly
elevated threadlike borders.Appears scaly with small atrophic areas incenter that resembles psoriasis or eczema;usually chronic, but dont tent to invade other
areas.Related to ingestion of or exposure to arsenic
containing compunds.
-
8/4/2019 Basal Cell Epithelioma2
7/16
Irradiation is used if the tumor location requires it orif the patient is elderly or debilitaded and might notwithstand surgery.
Cryotherapy with liquid nitrogen freezes and kills thecells.
Chemosurgey may be necessary for persistent orrecurrent lesions. Chemosurgery consist ofperiodic applications of a fixative paste (such as
zinc chloride) and subsequent removal of fixedpathologic tissue. Treatment continues until thetumor has been completely removed.
-
8/4/2019 Basal Cell Epithelioma2
8/16
Instruct the patiet to eat small frequent smallmeals that are high in protein. Suggesteggnog, pureed foods, or liquid protein
supplement if the lesins has invaded the oralcavity and is causing eating problems.Tell the patient to prevent the disease from
recurring, he needs to avoid excessive sun
exposure and use a strong sunscreen orsunshade to protect his skin from damage byultraviolet rays.
-
8/4/2019 Basal Cell Epithelioma2
9/16
Advise patient to relieve local inflammationfrom tropical flourouracil with coolcompresses or corticosteriod ointment.
Advise patient with noduloulcerative basalcell epithelioma to wash his face gentlywhen ulcerations and crusting occur;
scrubbing too vigorously may causebleeding.
-
8/4/2019 Basal Cell Epithelioma2
10/16
Waxy, sclerotic, yellow to white plaqueswithout distinct borbers occuring on thehead and the neck that looks like smallpatches of scleroderma.
-
8/4/2019 Basal Cell Epithelioma2
11/16
Incisional or excisional biopsy and histologicstudy may help to determine the tumortype and histologic subtype.
-
8/4/2019 Basal Cell Epithelioma2
12/16
Curettage and electrodesiccation offer goodcosmetic results for small lesions.
Tropical Flourouracil is commonly use for
superficial lesions. This medicationproduces mark irritation or inflammation inthe evolved tissue but no systemic effects
Microscopicalltrolled surgical excisioncarefully removes recurrent lesions, skingrafting may be required.
-
8/4/2019 Basal Cell Epithelioma2
13/16
-
8/4/2019 Basal Cell Epithelioma2
14/16
and calorieintake.
Promote earlymobility.Provideposition
changes
Teach patientto practiceaseptictechnique forcleansing,
medicatinglesions.
Teach patientthe importanceof need foradequatenutritional food
intake.
Advise patientto avoid directsun exposureof affectedarea.
to promotewellness
measure topromotewellness.
n : 107
Hematocrit0.29
Segmenters: 0.72
Lymphocytes: 0.19
Creatinine:135
-
8/4/2019 Basal Cell Epithelioma2
15/16
CUES/NDXprovidepositionchanges
GOAL OFOBJECTIVE
NURSINGINTERVENTION
RATIONALE
IMPLEMENTATION
EVALUATION
SUBJECTIVE::may sugat sabukol ni inahobjective:LesionImflammedneck
particularlyaround theaffected area.Poor skinturgor.On ngtfeeding.Dry lips
At the endof healthteachingclent will beable to:1. verbalize
understanding ofrecencondition
2. Identify itsnature andcomplication.3.utilizetreatment canbe done.
encourageclient toexpressthought freely.
To advise thepatient to
follow doctorsorderreligiously.
Assist patientin comfortableposition.
Inspectwounds daily
to identifycausative factors.
To promotecontinous
healing andassess thedegree ofimpairment.
To avoidaspiration andminimize
Impairmentpromote
Helpedclientexpressedthoughtsandfeelings.
Administered NGTfeeding.
Advised toregiously
Patienthaveverbalizedrecentconditionfreely.
Client haveidentifiedpreventivemeasuresfor causinginfection.
-
8/4/2019 Basal Cell Epithelioma2
16/16
NAME OFDRUG
MECHANISMOF ACTION
INDICATION/CONTAINDICATION
SIDEEFFECTS
NURSINGRESPONSIBILITIES
Brand name:
Genericname:Co amoxiclav
Classification:anti bacterial /anti biotic
Dosage:1.2mgs
Route:Intravenous
An AntibioticIn the class of
Drugs calledPinicillin itfights bacteriastapinfections itpreventbacterial cellwall synthesisduringreplication
Used primarilyfor the
treatmentOf infectiondue tobacterialagentinfections ofthe respiratorytractSkin structure,paranasalsinuses, otitismedia,sinusitis or
Dizziness,fatigue
,insomnia skinrashes, itchyeyes, fine ordry mouth,abnormaltastesensation,diarrhea,rectalbleeding
AdvanceEffect :
Always the 10rigths. Rights
of patient,drugs,dosage,route,frequency
Advised pt. toReportimmediatelyany unusalmanifestationof the adverseeffect after